Why Pfizer’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon


  • World
  • Tuesday, 10 Nov 2020

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/File Photo

NEW YORK (Reuters) - Work to distribute the experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE is gearing up after the companies announced successful interim data earlier on Monday, but it will not be coming to local pharmacies for the general public any time soon.

The data, which sent U.S. stocks to record highs [.N], showed that the two companies' experimental vaccine is 90% effective at preventing COVID-19. They are still awaiting data on safety, which could come later this month.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Exclusive-Sudan drops out of hunger-monitor system on eve of famine report
Coralogix acquires AI observability platform Aporia
Google Maps fails users in West Bank: investigation
Factbox-What to watch for ahead of US presidential inauguration
Heavy snowfall causes widespread outages in BiH
U.S. stocks close higher
Greece completes Crete-Attica electrical interconnection
Crude futures settle lower
Kilauea volcano erupts again in U.S. Hawaii
U.S. dollar ticks up

Others Also Read